APA (7th ed.) Citation

P, B., F, Z., PK, T., L, D., K, V., O, K., . . . D, S. (2026). Targeted antisense oligonucleotide therapy rescues PRPF31 expression in retinitis pigmentosa caused by a splicing mutation. Molecular therapy : the journal of the American Society of Gene Therapy. https://doi.org/10.1016/j.ymthe.2026.05.033

Chicago Style (17th ed.) Citation

P, Banik, et al. "Targeted Antisense Oligonucleotide Therapy Rescues PRPF31 Expression in Retinitis Pigmentosa Caused by a Splicing Mutation." Molecular Therapy : The Journal of the American Society of Gene Therapy 2026. https://doi.org/10.1016/j.ymthe.2026.05.033.

MLA (9th ed.) Citation

P, Banik, et al. "Targeted Antisense Oligonucleotide Therapy Rescues PRPF31 Expression in Retinitis Pigmentosa Caused by a Splicing Mutation." Molecular Therapy : The Journal of the American Society of Gene Therapy, 2026, https://doi.org/10.1016/j.ymthe.2026.05.033.